Is RDHL or REVB more undervalued in 2026?

CirclFi compares Redhill Biopharma Ltd. (RDHL) and Revelation Biosciences, Inc. (REVB) using 13 institutional-grade valuation models. RDHL has a Quality of Company score of 5.0/10 while REVB scores 4.1/10.

Which is a better buy — RDHL or REVB?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do RDHL and REVB valuations compare?

RDHL at $1.00 and REVB at $1.09 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

RDHL vs REVB Valuation Comparison 2026 — Intrinsic Value Analysis

RDHL

Pharmaceutical Preparations

Redhill Biopharma Ltd.

Quality

5.0

out of 10

Value Trap

SAFE

Price

$1.00

Last close

Models

10/13

Active

REVB

Pharmaceutical Preparations

Revelation Biosciences, Inc.

Quality

4.1

out of 10

Value Trap

LOW

Price

$1.09

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	RDHL Fair Value	RDHL Upside	REVB Fair Value	REVB Upside
Bayesian DCF	Intrinsic	$0.36	-63.7%	$2.19	+100.1%
Earnings Power Value	Intrinsic	$2.47	+142.5%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	—	—	$5.68	+418.8%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for RDHL vs REVB — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

RDHL vs REVB — Which Stock Is More Undervalued?

RDHL scores higher with a 5.0/10 quality rating vs REVB's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Redhill Biopharma Ltd. (RDHL) and Revelation Biosciences, Inc. (REVB) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

RDHL currently trades at $1.00 with a QOC of 5.0/10, while REVB trades at $1.09 with a QOC of 4.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).